Sabine Straus To Lead EMA's Pharmacovigilance Committee
Executive Summary
Dutch regulator Sabine Straus will take over as chair of the European Medicines Agency's Pharmacovigilance Risk Assessment Committee when the UK’s June Raine leaves the post this year.
You may also be interested in...
New CHMP Chair Sought As Salmonson’s Tenure At Key EMA Panel Ends
Tomas Salmonson, the longstanding chair of the European Medicines Agency's key scientific committee, the CHMP, is being replaced. The Swedish regulator has held the post for six years, the maximum time allowed.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.
English Funding For Aquipta Targets AbbVie’s Migraine Drug To 170,000 People
Aquipta is the first oral treatment that NICE has recommended for preventing chronic migraines in the fourth-line setting, and the second oral treatment for episodic migraines in the same setting. The drug has already secured reimbursement in Scotland, Sweden and Israel.